statins

tim mayleben
Biotech

Esperion tees up to launch cholesterol-busting meds—affordably

Esperion plans to sell its non-statin cholesterol-fighting drugs at a price that ensures patients prescribed them can actually afford them.
Amirah Al Idrus Jan 14, 2020 8:30am
Minimally invasive blood flow probe allows continuous monitoring Pixabay

HDL Therapeutics' device cuts plaque in hypercholesterolemia

Nov 11, 2019 10:35am
E-Tattoo takes the hassle out of heart monitoring

Medicines Company's PCSK9 drug hits phase 3 efficacy goals

Aug 26, 2019 8:25am
red blood cells

Esperion's LDL drug aces a third pivotal trial

May 23, 2018 11:10am
blurry lights

Esperion’s LDL treatment hits the mark in phase 3

Mar 7, 2018 10:37am
Spotlight

Esperion hits goal in LDL trial, pulls forward NDA target date

Aug 9, 2017 9:03am